CLOV · Insider trading · 13F holders · Congress trades
Clover Health Investments, Corp. (CLOV)
Who is buying and selling CLOV: company insiders on SEC Form 4, hedge funds and superinvestors on Form 13F, and members of Congress under the STOCK Act. Every figure links to the filing or page it comes from.
- 13F filers holding
- 1
- Insider buys, 90 days
- $0
- Insider sales, 90 days
- $4.2M
- Congress trades, 12 months
- 0
CLOV at a glance
- Between Aug 1, 2026 and Oct 29, 2026, 6 CLOV insiders filed 18 sales worth $4.2M on SEC Form 4, and no open-market purchases; 17 of the sales were pre-planned under Rule 10b5-1.
- 1 13F filer hold CLOV among their 50 largest positions, worth $6.8M combined. The biggest bets by portfolio weight are GMT Capital Corp (0.4%).
- No member of Congress has disclosed a trade in CLOV.
- CLOV last closed at $4.58 on Oct 29, 2026.
CLOV insider trading
Between Aug 1, 2026 and Oct 29, 2026, 6 CLOV insiders filed 18 sales worth $4.2M on SEC Form 4, and no open-market purchases; 17 of the sales were pre-planned under Rule 10b5-1.
| Filed | Insider | Role | Trade | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | Soares Karen | Chief Legal Officer | Sale10b5-1 | 19,275 | $4.66 | $90K | SEC |
| Oct 20, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sale10b5-1 | 4,066 | $4.41 | $18K | SEC |
| Oct 19, 2026 | Toy Andrew | Chief Executive Officer, Director | Sale10b5-1 | 62,176 | $4.68 | $291K | SEC |
| Oct 19, 2026 | Wai Conrad | CEO, Counterpart Health | Sale10b5-1 | 23,627 | $4.68 | $111K | SEC |
| Oct 19, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sale10b5-1 | 18,273 | $4.68 | $86K | SEC |
| Oct 19, 2026 | Soares Karen | Chief Legal Officer | Sale10b5-1 | 14,673 | $4.68 | $69K | SEC |
| Oct 19, 2026 | Thornton Joseph Clay | Interim CFO | Sale10b5-1 | 4,591 | $4.68 | $21K | SEC |
| Oct 7, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sale10b5-1 | 2,006 | $4.63 | $9K | SEC |
| Oct 5, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sale10b5-1 | 8,750 | $4.42 | $39K | SEC |
| Oct 2, 2026 | Toy Andrew | Chief Executive Officer, Director | Sale10b5-1 | 318,806 | $4.19 | $1.3M | SEC |
| Sep 18, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sale10b5-1 | 1,921 | $4.56 | $9K | SEC |
| Sep 17, 2026 | Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | Sale10b5-1 | 3,170 | $4.64 | $15K | SEC |
| Sep 16, 2026 | Wai Conrad | CEO, Counterpart Health | Sale10b5-1 | 300,000 | $4.72 | $1.4M | SEC |
| Sep 15, 2026 | Reynoso Jamie L. | CEO, Medicare Advantage | Sale10b5-1 | 9,273 | $4.78 | $44K | SEC |
| Sep 15, 2026 | Soares Karen | Chief Legal Officer | Sale10b5-1 | 6,846 | $4.78 | $33K | SEC |
| Sep 14, 2026 | Oldakowski Joseph Frank | VP OF FINANCE AND CONTROLLER | Sale | 20,000 | $5.16 | $103K | SEC |
| Aug 17, 2026 | Thornton Joseph Clay | Interim CFO | Sale10b5-1 | 17,775 | $4.39 | $78K | SEC |
| Aug 10, 2026 | Toy Andrew | Chief Executive Officer, Director | Sale10b5-1 | 87,798 | $4.65 | $408K | SEC |
Who owns CLOV? Hedge funds and superinvestors
1 13F filer hold CLOV among their 50 largest positions, worth $6.8M combined. The biggest bets by portfolio weight are GMT Capital Corp (0.4%).
| Manager | % of portfolio | Value | Shares | Last quarter | 13F |
|---|---|---|---|---|---|
| GMT Capital CorpHedge fund | 0.4% | $6.8M | 1,305,200 | +0.0% shares | Q2 2026 |
Each manager counts with its latest 13F (Q2 2026: 1). Screen CLOV in the grand portfolio →
CLOV stock trades by members of Congress
No member of Congress has disclosed a trade in CLOV.
CLOV questions and answers
Are insiders buying CLOV stock?
Between Aug 1, 2026 and Oct 29, 2026, 6 CLOV insiders filed 18 sales worth $4.2M on SEC Form 4, and no open-market purchases; 17 of the sales were pre-planned under Rule 10b5-1.
Which hedge funds own CLOV?
1 13F filer hold CLOV among their 50 largest positions, worth $6.8M combined. The biggest bets by portfolio weight are GMT Capital Corp (0.4%).
Has Congress traded CLOV?
No member of Congress has disclosed a trade in CLOV.
Who is the largest holder of CLOV?
Among 13F filers, GMT Capital Corp reports the largest CLOV position, $6.8M (1,305,200 shares) in its Q2 2026 13F. The biggest bet by portfolio weight is GMT Capital Corp's: 0.4% of its portfolio.
Cite or share this
Free to use with a link back. The data updates every filing day.